Joyce A. O'Shaughnessy, MD
US Oncology Research, McKesson Specialty Health · US Oncology Research
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joyce A. O'Shaughnessy, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:57 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06517212 · Tirzepatide Weight Loss for MRD+ Early Breast CancerBaylor Research Institute · recruiting · Breast Cancer, Breast Neoplasms, Breast Cancers
- Early Ph1NCT06008275 · Neratinib in Combination With Ruxolitinib in Patients With mTNBCBaylor Research Institute · recruiting · Metastatic Triple-Negative Breast Carcinoma, Breast Cancer
- N/ANCT04875351 · Breast Cancer Index (BCI) RegistryBiotheranostics, Inc. · active not recruiting · Breast Cancer
- Ph2NCT04032080 · LY3023414 and Prexasertib in Metastatic Triple-negative Breast CancerBaylor Research Institute · completed · Triple Negative Breast Cancer
- Ph2NCT02229136 · Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by EverolimusUS Oncology Research · completed · Stomatitis, Oral Mucositis, Neoplasm of the Breast · principal investigator
- Ph2NCT02187991 · Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast CancerUS Oncology Research · completed · Breast Cancer, Breast Carcinoma, Breast Tumors · principal investigator
- Ph2NCT02000882 · STAR Cape+BKM120 MBC With Brain MetUS Oncology Research · completed · Brain Metastases, Breast Cancer, Metastatic Breast Cancer · principal investigator
- N/ANCT01111175 · Triple Negative Breast Cancer Biomarker StudyUS Oncology Research · completed · Metastatic Breast Cancer, Triple Negative Breast Cancer
- Ph2NCT01036113 · A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast CancerEnzon Pharmaceuticals, Inc. · terminated · Metastatic Breast Cancer
- Ph2NCT00248287 · PhII ICb With/Without Erbitux in MBC PtsUS Oncology Research · active not recruiting · Metastatic Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.